{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:29:27Z","timestamp":1789352967828,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":3056,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30973467\/H1611"],"award-info":[{"award-number":["30973467\/H1611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ajpath.2011.05.005","type":"journal-article","created":{"date-parts":[[2011,6,14]],"date-time":"2011-06-14T04:21:05Z","timestamp":1308025265000},"page":"714-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis"],"prefix":"10.1016","volume":"179","author":[{"given":"Hua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad","family":"Lafdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogyi","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2011.05.005_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MCG.0b013e3181d46ef2","article-title":"Hepatocellular carcinoma (HCC): a global perspective","volume":"44","author":"Ferenci","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.22580","article-title":"Molecular mechanisms of hepatocellular carcinoma","volume":"48","author":"Aravalli","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.22704","article-title":"Liver stem cells and hepatocellular carcinoma","volume":"49","author":"Mishra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","article-title":"Diagnosis and treatment of hepatocellular carcinoma","volume":"134","author":"El-Serag","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.22506","article-title":"Molecular targeted therapies in hepatocellular carcinoma","volume":"48","author":"Llovet","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(09)60381-0","article-title":"Major achievements in hepatocellular carcinoma","volume":"373","author":"Bruix","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2011.05.005_bib8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1053\/j.gastro.2011.03.006","article-title":"Targeted therapies for hepatocellular carcinoma","volume":"140","author":"Villanueva","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumour microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2011.05.005_bib10","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2011.05.005_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2011.05.005_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.23633","article-title":"Sorafenib: where do we go from here?","volume":"52","author":"Siegel","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrc2734","article-title":"STATs in cancer inflammation and immunity: a leading role for STAT3","volume":"9","author":"Yu","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2011.05.005_bib14","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7150\/ijbs.7.536","article-title":"Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target","volume":"7","author":"Wang","year":"2011","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajpath.2011.05.005_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/intimm\/dxq030","article-title":"IL-6: from its discovery to clinical applications","volume":"22","author":"Kishimoto","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccr.2009.01.009","article-title":"Inflammation and cancer: IL-6 and STAT3 complete the link","volume":"15","author":"Bromberg","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2011.05.005_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ajpath.2011.05.005_bib18","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/hep.24339","article-title":"In vivo consequences of liver-specific interleukin-22 expression: implications for human liver disease progression","author":"Park","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543780802565791","article-title":"Targeting STAT3 in cancer: how successful are we?","volume":"18","author":"Yue","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ajpath.2011.05.005_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2009.12.048","article-title":"Hepatocyte IKK\u03b2\/NF-\u03baB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation","volume":"17","author":"He","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajpath.2011.05.005_bib22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/j.gastro.2008.01.016","article-title":"Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury","volume":"134","author":"Horiguchi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/hep.23430","article-title":"Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity","volume":"51","author":"Wang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib24","first-page":"4253","article-title":"Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse","volume":"43","author":"Vesselinovitch","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.005_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/0008-5472.CAN-09-3090","article-title":"The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis","volume":"70","author":"Fan","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.005_bib26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jhep.2009.09.008","article-title":"A novel model of CCl4-induced cirrhosis with ascites in the mouse","volume":"51","author":"Domenicali","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gut.2008.157420","article-title":"Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats","volume":"58","author":"Paik","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2011.05.005_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-2275(20)37347-8","article-title":"Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures","volume":"22","author":"Gavino","year":"1981","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2011.05.005_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ajpath.2011.05.005_bib32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(90)90208-Q","article-title":"Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples","volume":"190","author":"Baker","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ajpath.2011.05.005_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/onc.2008.448","article-title":"The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-\u03b2 signaling","volume":"28","author":"Lin","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2011.05.005_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20070820","article-title":"Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3","volume":"205","author":"Riehle","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2011.05.005_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hep.21951","article-title":"Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma","volume":"47","author":"Cui","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib36","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/hep.23892","article-title":"Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis","volume":"52","author":"Sharma","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib37","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/hep.23697","article-title":"c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair","volume":"52","author":"Machida","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","article-title":"Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS","volume":"110","author":"Hong","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2011.05.005_bib39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semcdb.2008.06.004","article-title":"Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling","volume":"19","author":"Regis","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0163-7258(96)00062-9","article-title":"N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation","volume":"71","author":"Verna","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajpath.2011.05.005_bib41","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.23747","article-title":"Conditional \u03b2-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor \u03b1\/phosphoinositide 3-kinase signaling","volume":"52","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2011.05.005_bib42","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1158\/0008-5472.CAN-05-4608","article-title":"Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression","volume":"66","author":"Farazi","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2011.05.005_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0030-1247135","article-title":"Mouse models of hepatocellular carcinoma","volume":"30","author":"Fausto","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ajpath.2011.05.005_bib44","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","article-title":"Experimental models of hepatocellular carcinoma","volume":"48","author":"Newell","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-230X-10-79","article-title":"Mouse model of carbon tetrachloride induced liver fibrosis: histopathological changes and expression of CD133 and epidermal growth factor","volume":"10","author":"Fujii","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib46","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20080003","article-title":"Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-\u03b2 and STAT3 activation","volume":"206","author":"Hosui","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2011.05.005_bib47","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cell.2005.04.014","article-title":"IKK\u03b2 couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis","volume":"121","author":"Maeda","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2011.05.005_bib48","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1440-1746.2008.05502.x","article-title":"8-Hydroxy-2\u2032-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection","volume":"23","author":"Chuma","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib49","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.coi.2008.03.010","article-title":"Role of Stat3 in suppressing anti-tumor immunity","volume":"20","author":"Kortylewski","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.ajpath.2011.05.005_bib50","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/hep.23532","article-title":"Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell-specific signal transducer and activator of transcription 3 gene knockout mice","volume":"51","author":"Horiguchi","year":"2010","journal-title":"Hepatology"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011004342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944011004342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:31:14Z","timestamp":1757601074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944011004342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0002944011004342"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.005","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2011.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}